Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization by unknown
Identification of the Major Physiologic 
Phosphorylation Site of Human Keratin 18: Potential 
Kinases and a Role in Filament Reorganization 
Nam-On Ku and M. Bishr Omary 
Palo Alto Veterans Administration Medical Center, Palo Alto, CA 94304; and the Digestive Diseases Center, Stanford University 
School of Medicine, Stanford, California 94305-5487 
Abstract.  There is ample in vitro evidence that phos- 
phorylation of intermediate filaments, including kera- 
tins, plays an important role in filament reorganiza- 
tion. In order to gain a better understanding of the 
function of intermediate filament phosphorylation, we 
sought to identify the major phosphorylation site of 
human keratin polypeptide 18 (K18) and study its role 
in filament assembly or reorganization. We generated 
a series of K18 ser---ala mutations at potential phos- 
phorylation sites, followed by expression in insect 
cells and comparison of the tryptic 32po4-1abeled pat- 
terns of the generated constructs. Using this approach, 
coupled with Edman degradation of the 32po4-1abeled 
tryptic peptides, and comparison with tryptic peptides 
analyzed after labeling normal human colonic tissues, 
we identified ser-52 as the major K18 physiologic 
phosphorylation site. Ser-52 in K18 is not glycosylated 
and matches consensus sequences for phosphorylation 
by CAM kinase, $6 kinase and protein kinase C, and 
all these kinases can phosphorylate K18 in vitro pre- 
dominantly at that site. Expression of K18 ser-52---ala 
mutant in mammalian cells showed minimal phos- 
phorylation but no distinguishable difference in fila- 
ment assembly when compared with wild-type K18. In 
contrast, the ser-52 mutation played a clear but nonex- 
clusive role in filament reorganization, based on analy- 
sis of filament alterations in cells treated with okadaic 
acid or arrested at the G2/M stage of the cell cycle. 
Our results show that ser-52 is the major physiologic 
phosphorylation site of human K18 in interphase cells, 
and that its phosphorylation may play an in vivo role 
in filament reorganization. 
I 
NTERMEDIATI~ filaments (IF)I consist of a broad family 
of nuclear (i.e.,  lamins)  and cytoplasmic (e.g.,  ker- 
atins,  neurofilaments  [NF],  vimentin,  desmin) cyto- 
skeletal  proteins  (reviewed  in  Steinert and  Roop,  1988; 
Klymkowsky et al., 1989; SkaUi and Goldman, 1991). The 
function(s) of the cytoplasmic IF remain largely unknown. 
However, recent identification of point mutations in a num- 
ber of epidermal keratins as a likely cause of three skin dis- 
eases (reviewed in Fuchs and Coulombe, 1992; Compton, 
1994) strongly support a structural/mechanical  integrity role 
at least for the epidermal keratins (Coulombe et al., 1991). 
For the glandular epithelial keratins,  a role in the integrity 
of fetal liver was demonstrated by a targeted null mutation 
in mouse keratin polypeptide 8 gene, with fetal lethality and 
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extensive hepatic hemorrhage in most mice (Baribault et al., 
1993). There is also evidence for keratins playing an impor- 
tant role in Xenopus gastrulation,  based on injection of anti- 
keratin antibodies (Klymkowsky et al., 1992) or injection of 
antisense oligodeoxynucleotides into oocytes (Torpey et al., 
1992). In the case of  neurofilaments, overexpression of  NF-L 
(Xu et al., 1993) and NF-H (Cote et al., 1993) in transgenic 
mice resulted in a disease resembling  amyotrophic lateral 
sclerosis. In addition, NF-deficient axons have a small cali- 
ber as noted in the NF-deficient Japanese quail (Ohara et al., 
1993) and in transgenic mice expressing an NF-/3-galactosi- 
dase fusion protein (Eyer and Peterson, 1994). These find- 
ings suggest that NF may play a role in axonal caliber and 
neuronal transmission. 
Although the function(s) of cytoplasmic IF is not fully un- 
derstood, it is likely that IF are similar to other proteins in 
that at least some aspects of their function are regulated by 
posttranslational  modifications they undergo. In the case of 
keratin polypeptide  8 and 18 (K8/18), which are the major 
keratin pair that is  expressed in glandular epithelia,  two 
potential regulatory posttranslational modifications are phos- 
phorylation (Celis et al., 1983; Baribault et al., 1989; Klym- 
kowsky et al.,  1991; Yano et al.,  1991; Chou and Omary, 
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phorylation of K8/18 using a number of kinases (Yano et al., 
1991), or enhanced phosphorylation of a number of keratins 
in  cells  arrested  in  mitosis  (Chou and Omary,  1993)  or 
treated with the phosphatase inhibitor okadaic acid (Yat- 
sunami et al., 1993) are associated with disassembly and re- 
arrangement of the keratin filaments. 
Phosphorylation of human K8 and  18 occurs on serine 
residues and increases dramatically after arresting cells at 
the  G2/M  stage  of the  cell  cycle using  anti-microtubule 
agents such as colcemid or nocodazole (Chou and Omary, 
1993).  In the case of K18, all the phosphorylation occurs 
within the NHE-terminal  125 amino acids which include the 
head and proximal rod domains (Chou and Omary,  1993). 
Recently, we coexpressed K8 and K18 in Spodopetra frug- 
iperda (Sf9) insect cells using recombinant baculovirus con- 
structs and showed that the expressed keratins can assemble 
into disorganized filaments (Ku and Omary, 1994). We also 
showed that phosphorylation and glycosylation of K8/18 is 
highly conserved among insect and human tissue cultured 
cells, particularly for K18 (Ku and Omary, 1994). For exam- 
ple, K18 expressed in insect Sf9 cells was phosphorylated on 
serine within the first 125 amino acid residues and showed 
a tryptic phosphopeptide pattern that was nearly identical to 
that seen in human colonic HT29 cells. The tryptic phos- 
phopeptide pattern of K18 in 32po4-1abeled HT29 and K18- 
recombinant baculovirus infected Sf9 cells showed several 
spots  consistent  with  phosphorylation  at  multiple  sites. 
However, one spot predominated as a major phosphopeptide 
in both cell types (Ku and Omary, 1994).  One noted differ- 
ence between insect and human tissue culture cells was in the 
KS:K18  phosphorylation ratio,  such that phosphorylation 
was K8>K18 in HT29 cells and K18>K8 in Sf9 cells (Ku and 
Omary,  1994). 
In this report, we first show that phosphorylation of K18 
and K8 in HT29 tissue culture cells is very similar to what 
is seen in ex vivo isolated normal colonic tissues. We then 
use a mutational approach of K18 coupled with expression 
in insect cells to identify ser-52 as the major phosphoryla- 
tion  site  of K18  in  interphase  cells.  A  ser-52---alanine 
(ala) mutation did not alter filament assembly in transfected 
mammalian cells, but did interfere with filament reorganiza- 
tion in cells arrested at the G2/M stage of the cell cycle or 
cells treated with okadaic acid. 
Materials and Methods 
Cell Culture, Tissues, and Reagents 
HT29 (human colon), NIH-3T3  (mouse fibroblast),  NMuLi (mouse liver) 
(American Type  Culture  Collection,  Rockville,  MD),  and SWI3  cells 
(Clone 1.1, vimentin positive human adrenal, kindly provided by Dr.  R. 
Evans, University of Colorado,  Denver, CO) were grown in media recom- 
mended by the providers.  Rectal biopsies were obtained from patients un- 
dergoing  routine colonoscopy  for polyp screening  under a  protocol ap- 
proved by the Medical Committee for the Protection of Human Subjects on 
Research at Stanford University.  The radiochemicals uridine diphosphate 
(UDP)  -  [4  -5-3H]galactose,  orthophosphate (32po4),  and  [~/-32plATP 
(3,000  Ci/mmol) were purchased from Du Font-New  England Nuclear. 
Other reagents used were: bovine milk galactosyltransferase,  myelin basic 
protein (MBP), and colcemid (Sigma Chem. Co., St. Louis, MO); Baculo- 
Gold transfection kit and SD insect cells (PharMingen, San Diego,  CA): 
phenyl isothiocyanate  (Pierce Chem. Corp.); okadaic  acid (LC Services, 
Woburn, MA). The cDNA for wild-type  (WT) human K8 and K18 were 
kindly provided by J. E  Strauss  (Yamamoto et al.,  1990) and R. Oshima 
(Oshima  et  al.,  1986),  respectively.  The  $6  and  calcium/caimodulin- 
dependent (CAM)  kinases were  gifts from James Mailer (University of 
Colorado, Denver, CO) and Howard Schulman (Stanford  University, Paio 
Alto, CA), respectively, and protein kinase C (PKC) o~ and ~ were obtained 
from Berta Strulovici  (Syntex Research, Palo Alto, CA). 
Construction  of  Mutants and 
Baculovirus Recombinants 
The eDNA for K8 and K18 were subeloned into the pBluescript SK+ plas- 
mid.  Site-directed  mutagenesis  to  generate  serine  (ser)~ala  mutants 
were carried out using a Transformer  TM kit (Clontech, Palo Alto, CA). This 
method is based on annealing two oligonucleotide  primers, one which in- 
troduces the desired mutation and the second which mutates a restriction 
site unique to the plasmid for selection (Deng and Nickoloff,  1992).  All 
primers contained 1-3 mutations with 8-10 nucleotides  flanking the first 
mutation on either end. Mutations at nonconsecutive serines were gener- 
ated using multiple primers, and all mutations were confirmed by sequenc- 
ing the mutagenized  regions of both strands.  Mutants were subeloned into 
the pVL1392 vector for expression in Sf9 cells, or downstream of  the hCMV 
promoter in pMRB101 mammalian expression vector (Stephens and Cock- 
ett,  1989). Generation of the baculovirus  recombinants was done exactly 
as described (Ku and Omary,  1994). 
Transient and Stable Transfection 
Transfection was done using LipofectAMINE TM liposomes (GIBCO BRL). 
Selection of stable transfectants  was done by growing cells in the presence 
of 250 #g/ml xanthine,  15 #g/ml hypoxanphine,  10 #g/ml thymidine,  2 
/zg/ml aminoptrin, 25/zg/ml mycopbenolic acid, 150/zg/ml glutamine, and 
fetal calf serum dialyzed against 0.15 M NaCl. Transfectants were then sub- 
cloned by limiting dilution.  Sodium butyrate was used to enhance the ex- 
pression of K8/18 in stably transfected  NIH-3T3  cells (Gorman et al., 
1983), before labeling cells with 32pO  4 . For this, cells were incubated with 
10 mM sodium butyrate (using 1 M stock solution) for 16-18 h before (and 
during) 32po4 labeling.  It resulted in a 3-5-fold increase in K8/18 expres- 
sion without affecting cell viability, IF phosphorylation  or organization (not 
shown). 
Immunofluorescence Microscopy 
Transfected mammalian cells, or Sf9 cells infected with K8/18 recombinant 
baculovirus constructs were grown on coverslips. Alternatively, transfected 
cells were treated with okadaic acid (1 #g/ml) for 30-60 min, or with col- 
cemid (0.5 pg/ml) for 36 h  followed by collection of floater  and easily 
released cells and transferring to slides using a Cytospin (700 rpm, 6 rain). 
Cells were then fixed in methanol (3 rain, -20°C), rinsed with PBS then 
PBS containing 2.5 % BSA. After washing, cells were incubated with mono- 
clonal anti-KS/18 antibody (termed L2A1; Chou and Omary,  1991) in PBS 
containing 2.5% BSA and 10% vol/vol of cytoplasmic cell extract obtained 
from similar nontransfected  cells (to block nonspecific binding). After 30 
min, slides  were  washed  then incubated with Texas red-conjugated  goat 
anti-mouse antibody (30 min, 22°C) in PBS containing 2.5% BSA,  10% 
(vol/vol) goat serum and 10% (vol/vol) nontransfected  cell cytoplasmic  ex- 
tract. 
For quantitation of filament  reorganization,  cells from each treatment 
were counted (102-278  cells/treatment condition of a  cell transfectant). 
Counted cells were categorized  as having an exclusive punctate pattern or 
a mixed punctate/filamentous pattern (grouped  as disrupted) or cells that 
lack any punctate pattern (grouped  as  normal filaments).  The percent 
reorganization  was  quantitated as  number of cells with disrupted fila- 
ments/number of cells with normal +  disrupted filaments  ×  100. Photos 
were taken using black and white Kodak TMAX 400 film. The mitotic in- 
dex (% G2/M cells) was determined using propidium iodide staining as de- 
scribed (Chou and Omary,  1993). 
Radiolabeling 
Human colon biopsies and tissue culture cells were labeled with 32pO  4 for 
3-6 h (250 #Ci/ml) in phosphate-free  RPMI 1640 medium containing 10% 
dialyzed fetal calf serum. K8/18 were then isolated by immunoprecipitation 
or high salt extraction as described below. Analysis of K8/18 glycosylation 
was done by labeling accessible K8/18 terminal GlcNAcs by galactosylating 
K8/18 immunoprecipitates using UDP-[3Hlgalactose  and galactosyltrans- 
ferase exactly as described (Ku and Omary,  1994). 
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Immunoprecipitation was used to analyze K8/18 from cells labeled metabol- 
ically with 32PO4, or to isolate keratins for further glycosylation analysis 
or kinase assays. For this, mammalian and insect cells were solubilized in 
1% NP-40 in PBS containing 10 mM EDTA, 0.1 mM phenylmethanesul- 
fonylfluoride (added fresh),  10 t~M leupeptin,  10/~M pepstatin,  and 25 
t~g/ml aprotinin (buffer A) (45 rain, 4°C). After removal of nuclei (10,000 
g; 10 vain), cell lysates were incubated with anti-K8/18 MAb conjugated to 
Sepharose beads (45 rain, 4"C) followed  by washing. Alternatively, keratins 
were isolated from 32po,1 labeled cells using high salt extraction (Acht- 
staetter et al., 1986) exactly as described (Chou et al., 1993). K8/18 was 
also isolated from normal colonic biopsies by homogenization of  the labeled 
tissue fragments in buffer A using a Dounce homogenizer, followed by cen- 
trifugation and immunoprecipitation. 
Biochemical Studies 
Tryptic glyco- and phosphopeptide mapping was carried out as described 
(Chou et al., 1993). In the case of 32PO4-1abelad  K8/18, individual keratins 
were isolated after  preparative SDS-PAGE by cutting K8 or K18 bands 
visualized by brief Coomassie blue staining followed by electrcelution then 
acetone precipitation.  Keratin precipitates were treated with tryptin (375 
/~g/ml in 80 t~l of 50 mM NH4HCO3) for 16 h followed by a lyophilization 
then analysis in the horizontal dimension by electrophoresis (pH 1.9 buffer) 
(Boyle et al., 1991) and in the vertical dimension by chromatography. 
Manual Edman degradation was carried out as described (Boyle et al., 
1991) using tryptic digests of K18 that were purified from in vivo 32PO  4- 
labeled HT29 or St9 cells. Individual peptides were not separated before 
modification with  phenyl  isothiooyanate in the case  of asynchronously 
growing HT29 cells,  since  >90%  of the  radioactivity contained  in the 
32PO4-1abeled tryptic digest was in the ser-52--containing peptide that was 
being studied. For analysis of the ser-52-containing phosphopeptide from 
G2/M arrested HT29 cells, the specific peptide was scraped from six cellu- 
lose chromatography plates. The 32po4-1abeled  peptide was then extracted 
using water (,~15,000 cpm) followed by manual Edman degradation. 
In Vitro Kinase Assays 
Phosphorylation of K8/18 immunoprecipitates obtained from HT29 cells 
was carried out using rat brain PKCc~ and ~ (Omary et al., 1992), CAM 
kinase (Hanson and Schulman, 1992), and Xenopus ribosomal $6 kinase 
II (Erikson et al., 1991). Immunoprecipitates were first boiled for 2 min to 
remove endogenous kinase activity. $6 kinase reactions were done in: 20 
mM Hepes (pH 7), 3.3 mM 2-mereaptoethanol, and 10 mM MgCI2. Other 
kinase reactions were done in 50 mM Pipes (pH 7), 5 rnM MgCI2, 10 mM 
MnCI2  which also contained: 5 mM CaCI2, 5 tzg/ml calmodulin (for CAM 
kinase); phorbol 12-myristate 13-acetate (1 ~M), diaeyi glycerol (4 #g/ml), 
phosphatidylserine (40/~g/ml) (for PKCc~ and e). In addition, the PKCc~ 
reaction contained 1 mM CaC12 and the PKC~ reaction contained  1 mM 
EGTA. All reactions were done in a total volume of 25 #1 that also con- 
tained 10 #M ATP and 5 #Ci of ['y-32p]ATP.  After addition of the respec- 
tive kinases (10 rain, 220C), 25 #1 of 10% glycerol, 4% SDS sample buffer 
was added (Laemmli,  1970). Samples were then analyzed by SDS-PAGE 
and autoradiography, or tryptic peptide mapping of purified K18. 
Results 
Phosphorylation ofK8/18 in Sf9 and HT29 
Cells Correlates with Phosphorylation in Normal 
Human Tissues 
We recently showed that phosphorylation of K8 and K18 ex- 
pressed in St9 insect cells was very similar to that noted in 
HT29 human colonic tissue cultured cells, particularly for 
K18  (Ku  and  Omary,  1994).  Before  embarking  on  the 
identification of K8 and K18 phosphorylation sites in Sf9 and 
HT29 model systems, we sought to confirm that the labeled 
phosphopeptides in HT29 cells reflect the physiologically la- 
beled sites in normal tissues. As shown in Fig.  1 A, K8/18 
can be phosphorylated after labeling biopsies of normal hu- 
man colon ex vivo with 32PO4. Incorporation of 32po4 into 
the type II keratin (i.e., K8) was higher than the type I keratin 
(i.e., K18) as seen in HT29 cells (Chou and Omary,  1993), 
Xenopus oocytes (Klymkowsky et al.,  1991) and rat hepato- 
Figure 1.  Comparison of hu- 
man K8 and K18 phosphoryla- 
tion in HT29 cells and normal 
colonic biopsies. (A) Normal 
mucosal rectal biopsies were 
obtained  from  two  patients 
undergoing  routine  colonos- 
copy for polyp screening. Af- 
ter  rinsing  in  RPMI  1640 
medium,  biopsies  were  cut 
into small pieces then labeled 
with 32PO4 for 3  h,  followed 
by detergent solubilization  and 
immunoprecipitation  using 
anti-K8/18 MAb  (lane b)  or 
normal mouse ascites (lane a). 
The radiograph was obtained 
by  exposing  the  Coomassie- 
stained gel shown. Arrowhead 
indicates  migration  of  anti- 
body used for immunoprecipi- 
tation. (B) K8 and K18 were 
individually  purified  (using 
SDS-PAGE  followed  by  cut- 
ting out  of individual bands 
and electroelution) from HT29 
cells  that  were  radiolabeled 
with phosphate, or from the labeled normal colonic biopsies used inA. Purified K8 and K18 were digested with trypsin for peptide mapping. 
Electrophoresis and chromatography were in the horizontal and vertical directions, respectively. Arrowheads correspond to origin of sample 
loading. Mixture maps (c and  f) contained tryptic digests a  +  b and d  +  e, respectively (1,000 cpm from each tryptic digest). Numbered 
arrows correspond to prominent peptides. 
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phopeptides of K8 and K18 isolated from normal human co- 
lon versus tissue cultured cells showed significant identity 
(Fig.  1 B). For example, all the numbered peptides for K8 
were shared and similar in labeling intensity (Fig. 1 B, c) ex- 
cept peptide 5 which was labeled primarily in normal colon. 
Similarly, the minor labeled peptides 2-5 of  K18 were shared 
although more prominent in HT29 cells, with peptide 1 being 
the major labeled species in normal colon and HT29 cells 
(Fig.  1 B) and in Sf9 cells (Ku and Omary, 1994; and see 
Fig.  3 below). 
Identification of  ser-52 as the Major Phosphorylation 
Site of Kl8 
In order to identify the major phosphorylation site of K18, 
we used a systematic approach of generating a series of K18 
constructs  that  contain  ser~aia  mutations  at  potential 
phosphorylation sites.  That approach was based on our bio- 
chemical data showing that phosphorylation of K18 in Sf9 
cells  (Ku  and  Omary,  1994)  and  HT29 cells  (Chou  and 
Omary, 1993) was localized to the NH2-terminai 125 amino 
acids after digestion of 32po4-1abeled K18 with HBr/HC1 at 
tryptophan (trp)  residues.  As  shown in  Fig.  2,  the NH2- 
terminal 125-amino acid domain of K18 contains 20 serine 
potential phosphorylation sites. The phosphorylation in St  x  ) 
cells of K18 constructs encompassing mutations of the first 
15 residues are shown in Fig. 3 A. Constructs b-g contained 
point mutations of the sequentially numbered serines shown 
in Fig. 2, and constructs h and i contained scattered point 
mutations.  Immunoprecipitation  of  K8/18  from  in  vivo 
32pO4-labeled  8t9  cells  expressing  the  various  constructs 
showed that constructs g and i had minimal phosphorylation 
of K18 as compared with the other constructs (Fig. 3, radio- 
graph), despite having equal levels of  expressed protein (Fig. 
3 A,  Coomassie stain). 
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Figure 2. Amino acid sequence and tryptic peptides of K18 head 
and proximal rod domains. Single letter abbreviations are used to 
show the amino acid sequence of human K18 beginning with the 
acetylated serine.  Horizontal  brackets enclose predicted trypsin 
digestion products. Serine residues are shown in bold italics and are 
numbered consecutively above the brackets, with numbers below 
indicating amino acid position. The beginning of the rod domain 
and end of the head domain are also shown. 
The tryptic phosphopeptide map of K18 constructs (Fig. 
3 B) showed that the major phosphopeptide indicated by an 
arrow in a  is seen in all the constructs except g and i. By 
using the constructs that contain the major phosphopeptide 
to eliminate potential sites, it can be inferred that the 15th 
serine (i.e., ser-52 in Fig. 2) is the likely major site of K18 
phosphorylation.  This  was  confirmed by constructing in- 
dividual ser-50 and ser-52 point mutations which are con- 
tained within the same tryptic peptide (Fig. 4). Of note, the 
ser-50 point mutation decreased the overall phosphorylation 
of K18 nearly fourfold whereas the ser-52 point mutation 
Figure 3.  Characterization of 
the  phosphorylation  of  K18 
serine  mutants  expressed  in 
Sf9  cells.  A  panel  of bacu- 
lovirus-K18 constructs  were 
generated that contained mul- 
tiple K18 ser--,ala mutations. 
The numbers  indicated with 
constructs b to i represent mu- 
tated  serines  shown as  con- 
secutive numbers  in  Fig. 2. 
(A)  Sf9  cells  were  infected 
with recombinant WT K8/18 
or a recombinant WT KS/mu- 
tant K18 baculovirus for four 
days, then labeled with 32po4 
for  3  h.  The  keratins  from 
each construct were then im- 
munoprecipitated  using anti- 
K8/18 MAb and analyzed by 
SDS-PAGE.  (B)  Individual 
phosphate labeled K18 bands 
were isolated as in Fig.  1 then 
analyzed  by  tryptic  peptide 
mapping. 
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Baculovirus-K18 constructs  that  contain  wild-type  K18, or  in- 
dividual ser-50-*ala or ser-52~ala mutants (which correspond to 
the consecutively numbered serine 14 and 15 in Fig. 2) were gener- 
ated and used with WT K8 to coinfect SD cells for 4 d. Cells were 
then labeled with 32PO4 followed by solubilization and immuno- 
precipitation of K8/18 (A) or analysis of K18 from each of the con- 
structs by tryptic peptide mapping (B). 
resulted in essentially total abolishment of  K18 phosphoryla- 
tion (Fig. 4). Abolishing most of the phosphorylation of K18 
via the ser-52-*ala mutation did not affect the phosphory- 
lation level of K8 (Fig. 4 A) or the peptide map pattern of 
K8 (not shown). 
In order to differentiate between partial phosphorylation 
at  ser-50  versus  a  ser-50~ala  induced  conformational 
change that decreases the efficiency of phosphorylation at 
ser-52,  we performed manual  Edman degradation of K18 
tryptic phosphopeptides. As shown in Fig. 5, Edman degra- 
dation of K18 tryptic phosphopeptides, which contained the 
peptide 5°STSFR  as the primary phosphopeptide,  resulted 
in release of phosphate after the third cycle. Therefore, ser- 
52, being the third residue of the ~°STSFR tryptic peptide, 
is the major phosphorylation site of K18. The presence of a 
single phosphorylation site in the peptide s°STSFR was also 
supported by finding that WT K18 and the ser-50 mutants 
have identical pI and an identical migration of the 32po,,- 
labeled isoelectric forms (not shown). 
We also compared the glycosylation of wild type K18, ser- 
50~ala  and  ser-52~ala  K18  mutants  and  found  that  all 
the constructs had similar glycosylation levels in K8 and K18 
when expressed in Sf9 cells, as determined by in vitro galac- 
tosylation (not shown). In addition, the tryptic glycopeptide 
pattern of the three K18 constructs was also very similar and 
no effect of the mutations on the tryptic glycopeptide pattern 
of coexpressed wild-type K8 was noted (not shown). 
Potential Kinases Involved in. 
K18 ser-52 Phosphorylation 
The sequence containing ser-52 is part of a consensus se- 
quence RXXSXR (see Fig. 2) for PKC, and RXXS for $6 
and CAM kinases (Pearson and Kemp, 1991). We tested the 
Figure 5. Edman  degradation of 32po4-1ab¢lod K18 isolated from 
St9 and HT29 cells. HI29 and Sf9 cells were labeled with 32PO4 
for 5 h followed  by isolation of  the labeled K18 after immunoprecip- 
itation and SDS-PAGE. After trypsinization, labeled peptides were 
subjected to three cycles of manual Edman degradation. A fraction 
(1/10) of the starting material and of each cycle product was sub- 
jected to electrophoresis. The position of free labeled phosphate 
and origin of samples are indicated. 
in vitro phosphorylation of K18 (immunoprecipitated from 
HT29 cells) using purified CAM and S6 kinases, PKCo~ and 
PKCe. As shown in Fig. 6 a, K18 was phosphorylated by all 
the tested kinases except PKCot. As a control, phosphoryla- 
tion of  MBP by the different kinases showed that while PKCa 
did not efficiently phosphorylate K18, it did phosphorylate 
MBP (Fig. 6 b). Analysis of the tryptic phosphopeptides of 
K18 labeled in vitro by the indicated kinases (Fig.  6, e-g) 
showed a very similar pattern to the in vivo phosphorylation 
shown in Fig. 1. Identity of peptides 1-3 shown in Fig. 6, e-g 
to peptides 1-3 shown in Fig.  1 was confirmed by analysis 
of peptide maps obtained after mixing K18 isolated from in 
vivo phosphate-labeled HT29 cells with K18 labeled in vitro 
by each of the kinases (not shown). This indicates that CAM 
and $6 kinases as well as PKCe are able to in vitro phos- 
phorylate the ser-52 containing peptide of K18. 
Expression of V~ld-type and ser-52~ala KI8 in 
Mammalian and Insect Cells and Analysis of  Keratin 
l~lament Assembly and Reorganization 
We examined the effect of the ser-52~ala mutation of K18 
on filament assembly in a number of expression cell systems 
using  immunofluorescence.  As  shown  in  Fig.  7,  mutant 
and wild-type K18 manifested similar assembly patterns in 
Sf9 cells, and in three mammalian cell lines containing en- 
dogenous vimentin (mouse NIH 31"3 and human SW13)  or 
mouse K8/18 (NMuLi). Similar assembly patterns were also 
Ku and Omary Human Keratin 18 Phosphorylation  165 Figure 6.  Phosphorylation of K18 by CAM and $6 kinases and 
PKCE. (a-d) An in vitro kinase assay, with the indicated kinases, 
was carried out using as a substrate MBP or four equivalent im- 
munopreeipitates of K8/18 isolated from HT29 cells as described 
in Materials and Methods. The radiograph was obtained by ex- 
posure of  the Coomassie blue panel shown. (e-g) K18 was purified 
using preparative SDS-PAGE from I(8/18 immunoprecipitates la- 
beled in vitro with CAM or $6 kinases, or PKCe. After electroelu- 
tion of the individual K18 bands, tryptic peptide mapping was car- 
ried  out  as  described  in  Materials  and  Methods. Arrowheads 
indicate origin where samples were spotted. Unlabeled arrow in g 
shows a labeled peptide that is only weakly seen after in vivo label- 
ing (Fig. 1). 
noted when wild-type K18 and the ser-52 mutant were ex- 
pressed in SW13  cells that lack vimentin (not shown). We 
were unable to analyze in vitro assembly (using  negative 
staining and electron microscopy) of K8/18 purified from the 
Sf9 cell expression system, due to lack of filament formation 
of the wild-type proteins despite normal filament formation 
of K8/18 isolated in a similar manner from HT29 ceils (not 
shown). Lack of in vitro filament assembly of Sf9 produced 
K8/18 could be related to interfering species that may copu- 
rify with the individual keratins or to the altered phosphory- 
lation ratio of K8/K18 in insect cells as compared with mam- 
malian cells (Ku and Omary,  1994). 
We also studied the effect of the ser-52 K18 mutation on 
K8/18 filament reorganization in tissue culture cells. This is 
based on in vivo and in vitro evidence indicating that phos- 
phorylation of IF is likely to play a role in filament reorgani- 
zation (reviewed by Eriksson et al.,  1992a). This was done 
in two ways.  First we induced a hyperphosphorylated state 
in  K8/18  transfected  cells  by  short-term  treatment  with 
okadaic acid, a phosphatase type 1 and 2A inhibitor (Bialo- 
jan and Takai,  1988), which results in reorganization of IF 
(Eriksson et al., 1992b; S  acher et al., 1992; Lee et al., 1992) 
including keratins (Yatsunami  et al.,  1993) in a number of 
cell types examined. As shown in Fig. 8, okadaic acid treat- 
ment of wild-type K8/18 transfected into NIH-3T3 cells (and 
SWl3  cells,  not  shown)  resulted in  rearrangement of the 
transfected filament network into small and large aggregate 
dots, or dots and short filaments (a and c). In contrast, treat- 
ment  of  ser-52--,ala  K18/WT  K8-transfected  cells  with 
okadaic acid resulted in a  less filament-destructive pheno- 
type manifested by many cells showing normal appearing 
filaments and some cells showing fine dots (Fig. 8, e and g). 
Longer treatment with okadaic acid (>1 h) resulted in com- 
plete  rearrangement  of K8/18  filaments  in  WT  and  ser- 
52--}ala transfectants (not shown). A second approach that 
we  utilized  was  to  arrest  WT  K18  and  K18  ser-52--,ala 
transfected SW13  cells at the G2/M stage of the cell cycle 
with  colcemid,  then examine the  extent of filament rear- 
rangement. As shown in Fig. 8 (b, d, f, and h), a similar pat- 
tern to that seen with okadaic acid was observed in that the 
ser-52 K18 mutant did not rearrange as well as the WT K18 
transfectant. Quantitation of the cells containing disrupted 
filaments  from  a  representative  experiment  showed  that 
okadaic acid treated cells had 47 and 27 % of the cells with 
disrupted  filaments  (for WT  and  ser-52  mutant,  respec- 
tively) and colcemid G2/M arrested ceils had 63 and 35 % 
of the cells with disrupted filaments (for WT and set-52 mu- 
tant, respectively). Although there was some variability in 
the percent of cells with rearranged filaments between ex- 
periments,  the ratio of percent filament rearrangement in 
WT versus ser-52 mutant K18 transfectants was always  re- 
producible (1.96  +  0.14, [n =  4], and 2.15  +  0.78 [n  =  4] 
for colcemid and okadaic acid treated cells, respectively). 
This near twofold effect was also confirmed when WT and 
ser-52--,ala  K18  transfectants  (okadaic  acid  or  colcemid 
treated)  were  analyzed  in  a  double-blinded  manner  (not 
shown). We did not analyze G2/M arrested NIH-3T3-trans- 
fected cells since their filaments were not disrupted after col- 
cemid treatment (not shown). 
Phosphorylation  of V~ld-type and ser-52-*ala K18 
Expressed in NIH-3T3 Cells 
The ser-52~ala mutation of K18,  expressed in  Sf9 cells, 
resulted in near total abolishment of K18 phosphorylation 
(Fig. 4), which predicts that a similar pattern should occur 
if the K18 mutant  is  expressed in mammalian cells.  This 
prediction was  tested and  as  shown in Fig.  9,  WT K8/18 
were phosphorylated in the expected pattern (i.e., KS>K18 
32po4-1abeling intensity) after expression in NIH-3T3 cells 
(lane a),  but  the phosphorylation of the  ser-52~ala  K18 
mutant was barely detectable (lane b).  This indicates that 
mutation of the major phosphorylation site of K18 in mam- 
malian cells abolishes most of K18 in vivo phosphorylation, 
and supports our biochemical and molecular characteriza- 
tion. Analysis of the phosphorylation of WT K8/18  in the 
same transfected ceils treated with okadaic acid showed that 
K8 and K18 become hyperphosphorylated with K18 having 
nearly similar phosphorylation levels to 1(8 (lane c). A simi- 
lar preferential hyperphosphorylation of K18 was also noted 
in  HT29 cells  treated with  okadaic  acid  (not shown).  In 
contrast,  okadaic  acid  treated  cells  transfected  with  ser- 
52---}ala  K18  showed  that  K8  became  relatively  more 
phosphorylated than K18 (lane d), indicating that the ser-52 
mutation prevented some phosphorylation of K18 but that 
other sites also become phosphorylated. Similar results were 
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cence of  transfccted  wild-type 
and  ser-52~ala  KI8  ex- 
pressed in  mammalian and in- 
sect  cells.  Sf9 cells  were in- 
fected with  recombinant  K8 
and KI8 (WT  or ser-52---,ala 
mutants) baculovirus  followed 
by analysis  of  filament  forma- 
tion  after  2 d of  infection.  Al- 
ternatively, NIH-3T3,  SWI3, 
or  NMuLi  cells were  tran- 
siently  cotransfected  with WT 
K8  and  WT  or  ser-52  KI8. Af- 
ter 3 d, ceUs were fixed  and 
analyzed  by  immunofluores- 
cence using anti-K8/18 MAb 
as described in  Materials and 
Methods.  Immunofluorcscence 
of  stably  transfected  cells  also 
showed a similar  staining  pat- 
tern (not  shown). 
also obtained in SW13, stably transfected with WT K8 and 
WT  or  ser-52~ala  K18, in  the  presence  or  absence  of 
okadaic acid (not shown). 
Discussion 
Set-52 Is the Major Physiologic Phosphorylation Site 
of  Kt8 in Interphase Cells 
The phosphorylation of human K18  appears to be highly 
conserved in that similar peptides are phosphorylated when 
analyzed in an insect cell expression system, human colonic 
tissue  cultured  or  normal  ceils.  For  example,  the  phos- 
phorylated peptides of K18 in normal intestine are nearly 
identical to those in human colonic tissue culture cells, with 
one predominant radiolabeled peptide (Fig. 1). This extends 
our recent findings showing that phosphorylation of 1(8 and 
K18 in HT29 cells and St9 insect cells is also similar (Ku 
and Omary, 1994), and indicates that the phosphorylation of 
K8/18 expressed in St9 cells is physiologically relevant in 
terms of the modified peptides. The baculovirus-Sf9 K8/18 
expression system allowed us to generate a panel of  K18 con- 
structs in large quantities that permitted biochemical studies. 
The generated K18 constructs contained multiple serial mu- 
tations at potential phosphorylation sites that allowed iden- 
tification of the 5°STSFR tryptic peptide as the major phos- 
phopeptide  of K18  (Fig.  3).  The  precise  location of the 
phosphorylation site was verified using Edman degradation 
of tryptic peptides  of 32PO4-1abeled K18  (Fig.  5)  and by 
generating specific point mutations (Fig. 4). In addition, the 
ser-52 K18 mutant expressed in mammalian cells was essen- 
tially not phosphorylated when compared to the wild-type 
expressed protein (Fig. 9).  These data support the conclu- 
sion that ser-52 is the major physiologic phosphorylation site 
of K18 in interphase ceils. 
It is possible that the ser-52  mutation, which abolished 
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eence  analysis  of K8/18 fila- 
ment  reorganization  in  cells 
treated with eolcemid or oka- 
daic  acid.  Stable  transfected 
NII-I-3T3 cells  were  treated 
with  okadaie  acid  (1  txg/ml) 
for 45  min,  and  transfeeted 
SWl3 cells were treated with 
colcemid 0.5 #g/ml for 36 h. 
Floater  cells  and  cells  de- 
tached simply by rinsing were 
pooled and transferred to slides 
using a Cytospin then stained 
with  anti-K8/18 MAb as de- 
scribed in Materials and Meth- 
ods.  Cell  viability  was  95- 
100%  (ok__a0~Jc-treated cells) 
and 50-60%  (colcemid-treated 
ceils). For colcemid treatment, 
the percent  of analyzed  cells 
that were in G2/M were 75 and 
74% for WT K18 and ser52~ 
ala KI8 transfectants,  respec- 
tively (not shown). Less than 
5 % of  the okadaic-treated cells 
and  '~50%  of the  colcemid- 
treated cells remained adhered 
in the dish. 
most of K18 phosphorylation, could have caused a confor- 
mational change that resulted in masking another presumed 
major phosphorylation site. Such a  scenario is unlikely for 
several reasons.  First, biochemical data based on cleavage 
at trp-125 (Fig. 2) showed that most of K18 phosphorylation 
is within the NH2-terminal  125-amino acid domain which 
contains 20 serines (Chou and Omary, 1993). As a comple- 
ment to the analysis of the first 15 serines shown in Fig. 3, 
analysis  of ser---ala mutations  of the  five remaining  ser- 
ines showed a similar phosphorylation level to wild-type K18 
(not shown). Second, preliminary mass spectrometry data of 
a  tryptic digest of purified K18 yielded a  prominent mass 
spectral peak that corresponded to the mass of a single phos- 
phate  plus  the  5°STSFR  peptide  (not  shown).  Third,  a 
significant conformational change  by the  ser-52~ala  mu- 
tation is unlikely,  at least to the extent that it did not ap- 
preciably alter filament assembly (Fig. 7).  Along the same 
line, the 75 % reduction in K18 phosphorylation in the ser- 
50--,ala mutant is likely related to a  decrease in the over- 
all phosphorylation of K18 because of the nearby location of 
ser-50  and  ser-52.  Of note,  the  ser-50--,ala  K18  mutant 
showed normal assembly, as determined by immunofluores- 
cence staining,  after transfection  into  NIH-3T3 cells  (not 
shown). 
The  49RSTSFR  sequence  of human  K18  appears  to  be 
unique  in  terms of being absent from other keratin head- 
domain  sequences  that  we  have examined from sequence 
data banks. It is also not present in Endo B, the mouse kera- 
The Journal of Cell Biology, Volume 127, 1994  168 Figure 9.  Phosphorylation of K8/18 in NIH-3T3 cells expressing 
WT or ser-52,ala K18 mutant in the presence or absence of 
okadaic acid. Duplicate dishes of  NIH-3T3 stable transfectant cells, 
expressing WT K8 and WT or ser-52~ala  K18, were incubated 
with 10 mM sodium butyrate for 16 h to enhance keratin expression 
then labeled with 32PO4 for 4 h (250/~Ci/ml). During the last 45 
rain of labeling, okadaic acid was added to one of the duplicate 
dishes followed  by immunoprecipitation and SDS-PAGE analysis. 
Exposure was for 40 h (lanes a and b) and 2 h (lanes c and d). 
Nearly equivalent K8/18 portions were loaded from the wild-type 
and mutant immunoprecipitates. 
tin which has 89.7 % amino acid sequence identity with hu- 
man K18 (Oshima et al., 1986). It remains to be determined 
if ser-51  in the sequence s°RSVWGG of mouse Endo B is 
functionally equivalent to ser-52 in human K18. 
Relationship between Glycosylation and 
Phosphorylation  of  108 
A  potential  functionally relevant  feature of K8  and  K18 
glycosylation and phosphorylation is that the K8 and K18 
molecules that are phosphorylated are not glycosylated and 
vice versa. This is based on metabolic labeling of HT29 cells 
with 3H-GlcNH~ or 32PO~ followed by isoelectric focusing, 
which showed that the labeled phospho- and glyco-K18 iso- 
forms do not overlap (Chou and Omary, 1993).  The mutual 
exclusiveness of each modification has been reported  for 
other phosphoproteins that have the single O-GlcNAc type 
of modification including RNA polymerase II (Kelly et al., 
1993)  and peptide chain initiation factor 2-associated p67 
(Datta  et  al.,  1989).  This  raises  the possibility that one 
modification may block the other or that each modification 
has separate functional role(s). In the case of K18, abolishing 
the major phosphorylation site had no significant effect on 
K18 glycosylation, which supports the hypothesis that these 
modifications have different functional roles. 
Potential Kinases Involved in 108 Phosphorylation 
The consensus sequence RXXSXR for PKC, $6, and CAM 
kinases corresponds to the sequence ORSTSFR  containing 
ser-52 of K18. Our in vitro phosphorylation data showed that 
the ser-52 containing peptide was a major phosphopeptide 
that was phosphorylated by all three kinases (Fig. 6). In vivo 
phosphorylation of K8/18  in  HT29  cells  was  previously 
shown to be calcium independent, based on unaltered K8/18 
phosphorylation in the presence of ionomycin and BAPTA/ 
AM which led to an elevation and decrease in intracellular 
calcium levels, respectively (Chou and Omary, 1991). This 
suggests that CAM kinases are less likely to be involved in 
K18 phosphorylation in interphase cells. 
Although our data suggest that PKCe and/or $6 kinase may 
phosphorylate K18 in vivo, other kinases could certainly be 
involved.  For  example,  cAMP-dependent protein  kinase, 
which was not examined in this study, may be involved since 
rat K8 and K18 can act as in vitro substrates for this kinase 
(Yano et al., 1991). However, 8-Br-cAMP had little effect on 
K8  and  K18  phosphorylation in  HT29  cells  (Chou  and 
Omary, 1991). 
Several criteria  support a  potential role  for a  calcium- 
independent PKC such as PKCE in K8/18 phosphorylation 
(Omary et al., 1992): (a) the lack of phosphorylation of K18 
by the calcium-dependent PKCo~  (Fig. 8), (b) the association 
of a PKC~ related kinase with K8 and K18 as determined 
using biochemical means and double immunofluorescence 
labeling, (c) the decrease of basal K18 phosphorylation by 
introducing a  pseudosubstrate of PKCe to  intact cells by 
scratch loading, and (d) inhibition of in vitro phosphoryla- 
tion of K8/18 immunoprecipitates by the associated kinase 
activity in the presence of PKC~ pseudosubstrate. In addi- 
tion,  23  of 37  identified PKC phosphorylation sites con- 
tained a hydrophobic residue in the +I position of a phos- 
phorylated serine (e.g., phe-53 of K18, Pearson and Kemp, 
1991). Furthermore, the presence of two basic residues, par- 
ticularly arginine,  in the  -3  and  +2  positions  is  highly 
favorable for phosphorylation by PKC (e.g., arg-49 and 54 
of K18, Kennelly and Krebs,  1991). Similar in vitro phos- 
phorylation of rat liver K8/18 was obtained using PKC and 
CAM kinases (Yano et al.,  1991). 
Functions to Consider for ser-52 Phosphorylation 
Several potential functions for IF phosphorylation can be 
considered, including the regulation of IF assembly, disas- 
sembly, and dynamic rearrangements, interaction with other 
IF-associated proteins, glycosylation, and signal transduc- 
tion. Of these potential functions, the role of phosphoryla- 
tion in IF disassembly and reorganization is the best studied. 
For example, in vitro phosphorylation of vimentin (Inagaki 
et al., 1987),  desmin 0nagaki et al., 1988),  K8/18 (Yano et 
al., 1991), NF (Gonda et al., 1990),  ot-internexin (Tanaka et 
al.,  1993),  and nuclear lamins (Peter et al.,  1991) resulted 
in IF disassembly, and microinjection of cAMP-dependent 
protein kinase into BHK cells (Lamb et al.,  1989)  caused 
rearrangement of the studied IE Also, mitotic arrest of BHK 
cells caused hyperphosphorylation of vimentin and desmin 
in association with IF disassembly (Chou et al., 1989),  and 
mitotic arrest of HT29 cells resulted in a similar change in 
K8/18 (Chou and Omary, 1993). Interestingly, phosphoryla- 
tion of the studied IF proteins occurs in the head, tail, or 
head/tail domains as shown for vimentin and desmin (Evans, 
1988),  KI  (Steinert,  1988),  NF  (Julien  and  Mushynski, 
1983; Nixon and Sihag, 1991), and K18 (Chou and Omary, 
1993).  These are the domains that appear to be important 
in IF assembly and dynamics (reviewed by Coulombe, 1993; 
Stewart,  1993;  Heins and Aebi,  1994). 
Our results showed that mutation of the major phosphory- 
lation site of K18 did not have an apparent role on filament 
assembly (Fig. 7) but did have a role on filament rearrange- 
ment that occurs in association with mitotic arrest or the in- 
duction of a hyperphosphorylated state in cells by okadaic 
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plete in that in the case of colcemid arrested cells for exam- 
ple,  '~60%  of the  WT  K18  transfected  cells  rearranged 
versus  30%  in ser-52~ala  K18  transfectants.  Such an in- 
complete effect is not surprising,  since phosphorylation of 
the K18 partner  (i.e.,  K8)  may be complementary or even 
dominant in having  a disassembly/rearrangement role. Our 
working hypothesis is that phosphorylation at multiple sites 
that  potentially  involve  both  keratins  will  be  important. 
Also, a simple on/offphosphorylation at a single site ofa het- 
eropolymeric protein pair may not necessarily occur, since 
multiple  sites  and multiple potential  rearrangements  with 
different functional consequences are likely to occur. For ex- 
ample, the double mutation at ser-22 and ser-392 of lamin 
A resulted in 56-73 % of cells being unable to disassemble 
their nuclear lamina, whereas mutation of the ser-22 alone 
resulted in only 35 % of the cells showing the mutant pheno- 
type (Heald and McKeon, 1990). The only other study of the 
in vivo effect of altering phosphorylation sites on filament as- 
sembly and reorganization  that we are aware of was done 
for  ser-55  in  vimentin,  which  is  a  site  phosphorylated 
by p34  ~2 (Carpenter  et al.,  1992). In that study, a ser-55--, 
ala mutation of vimentin resulted in normal assembly after 
transfection  into SWl3 cells lacking vimentin, but disassem- 
bly of the mutant protein did not occur during mitosis. In the 
case of K18, phosphorylation of the peptide containing ser- 
52 increases during mitotic arrest, but hyper- and neophos- 
phorylation  of four additional peptides also occurs (Chou 
and Omary,  1993).  Edman degradation of the 32PO4-1abeled 
ser-52  containing  peptide  (5°STSFR)  isolated  from G2/M 
arrested cells showed that ser-52 is the only phosphorylated 
serine in that peptide (not shown). 
Our identification of ser-52 as the major phosphorylation 
site of K18 in interphase  cells, and its potential role in fila- 
ment disassembly/rearrangement,  offers an impetus  and  a 
model system for further characterization  of the role of this 
and additional modification sites on filament rearrangement 
or interaction  with other cellular  elements.  For example, 
phosphorylation of IF may play a role in their interaction 
with pectin (Foisner et al.,  1991)  or other associated pro- 
teins,  in hepatocyte  response  to  epidermal  growth  factor 
(Baribault  et al.,  1989),  or in islet cell  insulin  secretion 
(Schubert and Fields, 1984). As additional modification sites 
become characterized and with the availability  of different 
modification mutants,  a full picture should emerge in terms 
of the roles of K8/18  phosphorylation and glycosylation in 
filament dynamics. 
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